V. Harrod

A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma

Karl J. Dykema, J. Trent, S. Byron, 2022, Cancer reports.

Development of new markers for hypoxic cells: [131I]Iodomisonidazole and [131I]Iodoerythronitroimidazole.

D. Podoloff, T. Inoue, R. Newman, 1996, Journal of drug targeting.

Low-dose Systemic Thrombolytic Therapy for Deep Vein Thrombosis in Pediatric Patients

S. Leary, P. D. de Alarcon, V. Harrod, 2010, Journal of pediatric hematology/oncology.

Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion

J. Trent, Jun S. Wei, S. Szelinger, 2021, Cancer Research.

Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease.

S. Dertinger, R. Ware, T. Howard, 2004, Experimental hematology.

Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy

Christopher D. Zysk, M. Zimmermann, C. Ida, 2018, Acta neuropathologica communications.

Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor.

Christopher D. Zysk, Asha A. Nair, C. Ida, 2019, Journal of Neuropathology and Experimental Neurology.

Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation–Sparing Approaches: An International Cohort Study

P. Northcott, J. Finlay, H. Toledano, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor.

Christopher D. Zysk, Asha A. Nair, C. Ida, 2019, Journal of neuropathology and experimental neurology.

Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy

Michael T. Zimmermann, Christopher D. Zysk, Asha A. Nair, 2018, Acta Neuropathologica Communications.